-
-
-
-
-
-
-
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
-
-
-
-
-
-
-
LifeMD secures $50 million credit facility with Citizens Bank
-
-
-
-
-
-
-
LifeMD reduces cash prices for Wegovy and Ozempic to $199 monthly
-
-
-
-
-
-
-
LifeMD offers Ozempic at $499 monthly via Novo Nordisk partnership
-
-
-
-
-
-
-
LifeMD to Report Second Quarter 2025 Financial Results on August 5
-
-
-
-
-
-
-
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs
-
-
-
-
-
-
-
LifeMD® Announces Entry Into the Behavioral Health Market
-
1,207,718 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

